Merck : MRK

All Merck Articles

1096 Articles

Douglas A. McIntyre | Dec 4, 2007 at 9:32 AM EST

Merck (MRK) Estimates Miss Street

Merck (MRK) is not going to do as well as Wall St. had hoped next year. It guided to $3.28…

Douglas A. McIntyre | Nov 9, 2007 at 8:29 AM EST

Pre-Market Stock News (November 9, 2007)

Allscripts (MDRX) traded down 25% after missing earnings estimates and after lower guidance for 2007 and 2008. American Tower (AMT)…

Douglas A. McIntyre | Nov 9, 2007 at 6:13 AM EST

Vioxx: Merck (MRK) Settled Too Early, Much Too Early

It has been a bloody and bitter fight. Merck’s (MRK) pain killer Vioxx has been alleged to cause heart problems…

Douglas A. McIntyre | Nov 8, 2007 at 12:08 PM EST

Defensive Stocks Show Rotation Out of Tech (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

The markets haven’t fallen apart after yesterday’s 360 point dive on the DJIA, but we are still trading a tad…

Douglas A. McIntyre | Nov 6, 2007 at 8:37 AM EST

GTX Soaring On Merck Collaboration (GTXI, MRK)

GTx, Inc. (NASDAQ: GTXI) is seeing shares trade sharply higher on a collaboration pact with Merck (NYSE: MRK). The biotech…

Douglas A. McIntyre | Nov 1, 2007 at 12:30 PM EDT

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks…

Douglas A. McIntyre | Oct 22, 2007 at 6:49 AM EDT

Merck (MRK) Comes Through

Merck (MRK) announced third-quarter 2007 earnings per share of $0.75, excluding restructuring charges, and third-quarter reported EPS of $0.70. Worldwide…

Douglas A. McIntyre | Oct 19, 2007 at 7:57 AM EDT

DJIA Components 20 Years After The Crash (MO, GM, IBM, MCD, MRK, MMM, PG, UTX) Part 2

Astoday is the 20th anniversary of the 1987 stock market crash, 24/7 WallSt. wanted to go back in time to…

Douglas A. McIntyre | Sep 18, 2007 at 5:25 AM EDT

Merck’s Big Test

Merck’s (MRK) has won almost every liability case it has faced over side-effects of its pain killer Vioxx. It has…

Douglas A. McIntyre | Sep 18, 2007 at 3:45 AM EDT

Media Digest 9/18/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Nokia (NOK) said the the ITC has begin an investigation into Qualcomm (QCOM) trade practives and patent…

Douglas A. McIntyre | Sep 7, 2007 at 3:32 PM EDT

Defensive Stock Picks Better Than The Market (September 7, 2007)

We are frequently asked about how certain basket picks perform compared to the overall market. It has been years since…

Douglas A. McIntyre | Sep 7, 2007 at 9:46 AM EDT

“Time To Go Defensive, Again?” (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

If you ever heard the old saying "Be careful what you wish for, you may get it!" it sure seems…

Douglas A. McIntyre | Sep 5, 2007 at 5:00 AM EDT

Pfizer: Stay On That Lipitor

Patients who swtich from Pfizer’s (PFE) monster selling drug cholesterol pill Lipitor to Merck’s (MRK) Zocor, now available in generic…

Douglas A. McIntyre | Aug 31, 2007 at 4:50 AM EDT

The Ariad Pharmaceuticals Conundrum (ARIA, MRK)

Business Week has run a brief feature article on Ariad Pharmaceuticals (NASDAQ:ARIA) in its "Inside Wall Street" magazine section and…

Douglas A. McIntyre | Aug 28, 2007 at 9:19 AM EDT

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s,…

1 … 70 71 72 73 74

Merck : MRK

All Merck Articles

Merck (MRK) Estimates Miss Street

Pre-Market Stock News (November 9, 2007)

Vioxx: Merck (MRK) Settled Too Early, Much Too Early

Defensive Stocks Show Rotation Out of Tech (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

GTX Soaring On Merck Collaboration (GTXI, MRK)

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Merck (MRK) Comes Through

DJIA Components 20 Years After The Crash (MO, GM, IBM, MCD, MRK, MMM, PG, UTX) Part 2

Merck’s Big Test

Media Digest 9/18/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Defensive Stock Picks Better Than The Market (September 7, 2007)

“Time To Go Defensive, Again?” (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Pfizer: Stay On That Lipitor

The Ariad Pharmaceuticals Conundrum (ARIA, MRK)

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Merck : MRK

All Merck Articles

Merck (MRK) Estimates Miss Street

Pre-Market Stock News (November 9, 2007)

Vioxx: Merck (MRK) Settled Too Early, Much Too Early

Defensive Stocks Show Rotation Out of Tech (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

GTX Soaring On Merck Collaboration (GTXI, MRK)

Defensive Stocks Show No Panic Rotation (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Merck (MRK) Comes Through

DJIA Components 20 Years After The Crash (MO, GM, IBM, MCD, MRK, MMM, PG, UTX) Part 2

Merck’s Big Test

Media Digest 9/18/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Defensive Stock Picks Better Than The Market (September 7, 2007)

“Time To Go Defensive, Again?” (PEP, KO, BUD, TAP, KFT, CAG, CPB, HRL, MCD, MO, VGR, RAI, PG, CL, MRK, JNJ, NVO)

Pfizer: Stay On That Lipitor

The Ariad Pharmaceuticals Conundrum (ARIA, MRK)

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income